European Archives - Page 832 of 1165 - European Medical Journal

Neuropsychological and Brain Grey Matter Volume Changes After Computer-Assisted Cognitive Treatment in Patients with Multiple Sclerosis

Cognitive impairment is a common disorder in multiple sclerosis (MS), present in >65% of patients both in the early and advanced phases of the disease…

Congress Feature from EAN 2018

During this year’s EAN Congress, the EMJ team attended the much-anticipated final presidential symposium chaired by Prof Günther Deuschl as President of…

Pilot Study of Balance Training Using Visual Biofeedback in People with Multiple Sclerosis with Balance Impairment

Impaired balance is common in people with multiple sclerosis (MS) and can be present even in persons with a mild disability level. With increasing…

Editor's Pick: Palliative Care in Neurology: Integrating a Palliative Approach to Amyotrophic Lateral Sclerosis Care

This narrative review examines connections between neurology, specialist palliative care, and an integrated palliative approach to care for people living…

Efficacy and Safety of Combined Open-Closed Loop Vagus Nerve Stimulation

Vagus nerve stimulation (VNS) is a neurostimulation therapy in which the vagus nerve is stimulated in the neck region by a helical electrode that is…

Behçet’s Disease and Neuro-Behçet’s Syndrome

Behçet’s disease is an idiopathic chronic relapsing multisystem vascular-inflammatory disease of unknown origin, which usually presents with orogenital ulceration and uveitis and is identified as the triple-symptom complex.

Disease-Modifying Treatment in Paediatric-Onset Multiple Sclerosis: A Danish Nationwide Population-Based Observational Study

Multiple sclerosis (MS) with onset before the age of 18 years is characterised by higher relapse rates and more severe MRI evidence of inflammation…

Spatial Patterns of the Tau-Immunoreactive Inclusions in Eight Different Tauopathies are Consistent with the Spread of Pathogenic Tau

Tauopathies are a major group of neurodegenerative disorders characterised by the presence of tau-immunoreactive inclusions in the cytoplasm of neurons…

Plasmapheresis for Neuromyelitis Optica: A Review from the Transfusion Medicine Specialist’s Perspective

Neuromyelitis optica is characterised by severe visual impairment and neurologic dysfunction, and aggressive plasmapheresis treatment is often recommended.

Clinical Characteristics of Intracranial Haemorrhages by Direct-Acting Anticoagulants in Secondary Prevention

The risk of systemic or intracranial haemorrhagic complications in patients with anticoagulated cardioembolic stroke is double that in primary prevention.